Tetzlaff Fabian, Hoebel Jens, Epping Jelena, Geyer Siegfried, Golpon Heiko, Tetzlaff Juliane
Medical Sociology Unit, Hannover Medical School, Hanover, Germany.
Division of Social Determinants of Health, Robert Koch Institute, Berlin, Germany.
Front Oncol. 2022 Apr 14;12:827028. doi: 10.3389/fonc.2022.827028. eCollection 2022.
Cancer represents a major burden of morbidity and mortality globally. So far, however, little is known on time trends and inequalities in the lengths of life spent free of any cancer. This study steps into this gap by analyzing time trends and income inequalities in cancer-free life expectancy (CFLE). For this retrospective cohort study, data of a large German health insurer were used (N = 3,405,673individuals, 2006-2018). Income inequalities were assessed using individual income (<60% of German average income (GAI) and ≥60% of GAI). Trends in incidence risks were analysed employing proportional-hazard regression models by splitting the observation time into three periods of 52 months. Trends in CFLE in total and for the most common site-specific cancers were calculated based on multiple decrement life tables. Incidence rates declined in almost all cancers and CFLE increased substantially over time (49.1 (95% CI 48.8-49.4) to 51.9 (95% CI 51.6-52.2) years for men, 53.1 (95% CI 52.7-53.5) to 55.4 (95% CI 55.1-55.8) years for women at age 20 for total cancer) and income groups. Considerable income inequalities in cancer risks were evident in both sexes, but were more pronounced in men (total cancer HR 0.86 (95% CI 0.85-0.87)), with higher-income individuals having lower risks. The highest income inequalities were found in colon (HR 0.90 (95% CI 0.87-0.93)), stomach (HR 0.78 (95% CI 0.73-0.84)), and lung cancer (HR 0.58 (95% CI 0.56-0.60)) in men. A reverse gradient was found for skin (HR 1.39 (95% CI 1.30-1.47) men; HR 1.27 (95% CI 1.20-1.35) women) and prostate cancer (HR 1.13 (95% CI 1.11-1.15)). The proportion of CFLE in total life expectancy declined for lung, skin and cervical cancer in women, indicating a relative shortening of lifetime spent cancer-free. In contrast, increasing proportions were found in breast and prostate cancer. To our knowledge, this is the first study analysing trends and income inequalities in CFLE. The life span free of cancer increased clearly over time. However, not all cancer types contributed equally to this positive development. Income inequalities persisted or tended to widen, which underlines the need for increased public health efforts in socioeconomically vulnerable groups.
癌症是全球发病和死亡的主要负担。然而,迄今为止,对于无癌生存时长的时间趋势和不平等现象知之甚少。本研究通过分析无癌预期寿命(CFLE)的时间趋势和收入不平等情况,填补了这一空白。在这项回顾性队列研究中,使用了一家大型德国健康保险公司的数据(N = 3,405,673人,2006 - 2018年)。使用个人收入(<德国平均收入(GAI)的60%和≥GAI的60%)评估收入不平等情况。通过将观察时间分为三个52个月的时间段,采用比例风险回归模型分析发病风险趋势。基于多重递减生命表计算总体和最常见部位特异性癌症的CFLE趋势。几乎所有癌症的发病率均下降,且随着时间推移CFLE大幅增加(20岁男性总体癌症的CFLE从49.1(95%CI 48.8 - 49.4)年增至51.9(95%CI 51.6 - 52.2)年,女性从53.1(95%CI 52.7 - 53.5)年增至55.4(95%CI 55.1 - 55.8)年),不同收入组情况类似。两性在癌症风险方面均存在显著的收入不平等,但男性更为明显(总体癌症风险比HR 0.86(95%CI 0.85 - 0.87)),高收入个体风险较低。男性中,结肠癌(HR 0.90(95%CI 0.87 - 0.93))、胃癌(HR 0.78(95%CI 0.73 - 0.84))和肺癌(HR 0.58(95%CI 0.56 - 0.60))的收入不平等最为严重。皮肤癌(男性HR 1.39(95%CI 1.30 - 1.47);女性HR 1.27(95%CI 1.20 - 1.35))和前列腺癌(HR 1.13(95%CI 1.11 - 1.15))呈现相反梯度。女性中,肺癌、皮肤癌和宫颈癌在总预期寿命中CFLE的比例下降,表明无癌生存时间相对缩短。相比之下,乳腺癌和前列腺癌的比例则有所增加。据我们所知,这是第一项分析CFLE趋势和收入不平等的研究。无癌寿命随着时间推移明显增加。然而,并非所有癌症类型对这一积极进展的贡献相同。收入不平等持续存在或有扩大趋势,这凸显了在社会经济弱势群体中加大公共卫生工作力度的必要性。